UAB Digital Repository of Documents 2 records found  Search took 0.01 seconds. 
1.
15 p, 1.4 MB Critical role of interleukin (IL)-17 in inflammatory and immune disorders : An updated review of the evidence focusing in controversies / Ruiz de Morales, José María G. (Universidad de León) ; Puig, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina) ; Daudén, Esteban (Hospital Universitario de la Princesa (Madrid)) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Pablos, José Luis (Hospital Universitario 12 de Octubre (Madrid)) ; Martín, Antonio Oliveira (Hospital Universitario La Paz (Madrid)) ; Juanatey, Carlos González (Hospital Universitario Lucus Augusti (Lugo)) ; Adan Civera, Alfredo (Hospital Clínic i Provincial de Barcelona) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Borruel, Natalia (Hospital Universitari Vall d'Hebron) ; Ortí, Guillermo (Vall d'Hebron Institut d'Oncologia) ; Holgado-Martín, Esther (Ruber Internacional) ; Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ; Vizcaya-Morales, Cynthia (Novartis Pharma) ; Martín-Vázquez, Víctor (Novartis Farmacéutica) ; González-Gay, Miguel Ángel (Universidad de Cantabria)
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive research because of its crucial role in the pathogenesis of different diseases across many medical specialties. [...]
2020 - 10.1016/j.autrev.2019.102429
Autoimmunity Reviews, Vol. 19 Núm. 1 (january 2020) , p. 102429  
2.
10 p, 1.0 MB Immunosenescence in multiple sclerosis : the identification of new therapeutic targets / Dema, María (Hospital Universitari Vall d'Hebron) ; Eixarch, Herena (Hospital Universitari Vall d'Hebron) ; Villar, Luisa M. (Hospital Universitario Ramón y Cajal (Madrid)) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Espejo, Carmen (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The number of elderly multiple sclerosis (MS) patients is growing, mainly due to the increase in the life expectancy of the general population and the availability of effective disease-modifying treatments. [...]
2021 - 10.1016/j.autrev.2021.102893
Autoimmunity Reviews, Vol. 20 Núm. 9 (september 2021) , p. 102893  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.